BIOTECHNOLOGY IN INDIA - An Indian Market Report - 佐思信息咨询

echinoidclapBiotechnology

Dec 1, 2012 (4 years and 4 months ago)

343 views


BIOTECHNOLOGY IN INDIA
-

An Indian
Market Report

联系购买电话:
〱0
-
㠲㠶㌴㠰8
公司名称:
佐思信息

公司地址:
北京市海淀区
苏州街
18
号院长远天地大厦
A2


1008
-
1
室(
100080



出版日期:
䅰物氠㈰ㄱ

周楳⁲数潲琠慮慬祺敳⁴桥慲步琠景爠䉩潴散桮潬潧礠楮⁉湤楡⁩渠
啓␠浩汬楯U

批⁴桥⁦潬汯睩湧⁋敹⁓散瑯牳‿䉩b
-
偨慲浡捥畴楣慬猬⁂楯
-
䅧物捵汴畲攬⁂楯
-
䥮摵獴物慬Ⱐ䉩潩湦潲浡瑩捳Ⱐ慮搠䉩I
-
卥牶楣敳⸠䅮湵慬S
敳瑩浡瑥猠慮搠景牥捡獴猠慲攠灲潶楤敤p景爠瑨攠灥物潤p㈰〹2瑨牯畧栠㈰ㄷ2
䅬獯Ⱐ愠獩A
-
祥慲⁨楳瑯物挠慮慬祳楳⁩猠灲潶楤敤⁦潲⁴桥獥y
牫整献⁔桥r
牥灯牴⁰牯晩汥猠㄰㌠捯浰慮楥猠楮捬畤楮朠浡湹敹⁡湤楣桥⁰污祥牳r
獵捨⁡猠䅤癡湣敤⁅湺祭敳⁔散桮潬潧楥猠䱴搮Ⱐ䅪敥琠卥敤猠䱴搮Ⱐ䅮瑨敭s
䉩潓捩敮捥猠偶琮⁌瑤⸬⁂桡牡琠䉩潴散栠䥮瑥牮慴楯湡氠䱩浩瑥搬⁂桡牡琠
卥牵浳⁡湤⁖慣捩湥猠䱴搮Ⱐ䉩潣潮⁌業楴敤S

卹湧敮攠䥮瑥牮慴楯湡氠
䱩浩瑥搬⁄爮⁒敤摹❳⁌慢潲慴潲楥猠䱴搮Ⱐ䕣牯渠䅣畮潶愬⁅汩⁌楬汹⁡湤L
䍯浰慮礠⡉湤楡⤠偶琮⁌瑤⸬⁇污硯卭楴桋汩湥⁐桡牭慣敵瑩捡汳⁌瑤⸬C
䥮摩慮⁉浭畮潬潧楣慬猠䱴搮Ⱐ䩵扩污湴⁌楦攠卣楥湣敳⁌業楴敤Ⱐ
䭲楳桩摨慮⁓敥摳⁐物癡瑥⁌業楴敤Ⱐ䱡浢K
愠周敲慰敵瑩挠剥獥慲捨⁌瑤⸬a
䵡桹捯Ⱐ䵡砠乥敭慮Ⱐ䵯湳慮瑯Ⱐ乯癯⁎潲摩獫⁉湤楡⁐癴⸠䱴搮Ⱐ乯癯穹浥猠
卯畴栠䅳楡⁐癴⸠䱴搮Ⱐ乵穩癥敤甠卥敤猠偶琮⁌瑤⸬⁏捩浵洠䉩潳潬畴楯湳S
䱴搮Ⱐ偡湡捥愠䉩潴散⁌瑤⸬⁐楲慭慬⁈敡汴档慲攠䱩浩瑥搬⁑畩湴楬敳L
䥮摩愬⁒慳椠卥敤猠⡐⤠I
瑤⸬⁒敬楡湣攠䱩晥⁓捩敮捥猬⁓敲畭⁉湳瑩瑵瑥t
潦⁉湤楡⁌瑤⸬⁓桡湴桡⁂楯瑥捨湩捳⁌業楴敤Ⱐ卉剏⁃汩湰桡牭Ⱐ却牡湤o
䱩晥⁓捩敮捥猬⁖敥摡⁃汩湩捡氠剥獥慲捨⁌業楴敤Ⱐ慮搠噩浴愠䱡扳L
䱩浩瑥搮⁍慲步琠摡瑡⁡湤⁡湡汹瑩捳⁡牥⁤敲楶敤⁦牯洠灲業慲礠慮搠
獥捯湤慲礠牥獥慲s
栮⁃潭灡湹⁰牯晩汥猠慲攠浯獴汹⁥硴牡捴敤⁦牯洠啒䰠
牥獥慲捨⁡湤⁲数潲瑥搠獥汥捴湬楮攠獯畲捥献r


呁䉌䔠但⁃低呅乔匠





B䥏呅T䡎佌O䝙⁉丠䥎䑉D
䍯C灬整e⁒ 灯牴)

偡来猠s‴〲






ㄮ⁎呒佄啃呉低Ⱐ䵅呈佄佌佇夠☠偒佄啃吠䑅䙉义呉低匮⸮⸮⸮ㄴ






却畤礠剥汩慢S
汩瑹⁡湤⁒数潲瑩湧⁌業楴慴楯湳⸮⸮⸮⸱





䑩獣污業敲献⸮⸮⸮D





䑡瑡⁉湴敲灲整慴楯渠☠剥灯牴楮朠䱥癥氮⸮⸮⸮D

Quantitative Techniques & Analytics.......3

Product Definition and Scope of Study.......3





Bio
-
Pharmaceuticals.......4

Bio
-
Agriculture......
.4

Bio
-
Industrial.......4

Bioinformatics.......4

Bio
-
Services.......4




2. OUTLOOK.......5






Current & Future Analysis.......51



Recession and Foreign Exchange Rate Decelerate Industry
Growth.......6

Industry Emerges Strong Following Recession.......6

Brighter Prospects Ahead for the Indian Biotech
Industry.......61


3. INDUSTRY OVERVIEW.......79






SWOT Analysis.......71



Diversity ?Key Strength for the Industry.......8

Major Sectors in the Indian Biotechnology Industry.......81



Government Suppor
t for Biotech Innovation ? A Boost for the
Industry.......9

Challenges Ahead.......91



Concerted Efforts are On to Find a Way Out.......10

Major Industry
-
Specific Advantages of the Indian Biopharma
Sector.......101



Competition.......11

Table 1: Leading
Biotech Companies in India by Revenues: 2009
-
10 (includes corresponding Graph/Chart).......111



Table 2: Leading Domestic Biotech Companies in India by
Revenues: 2009
-
10 (includes corresponding Graph/Chart).......12

Exports ?A Major Market for Indian Biot
ech Industry.......121



Table 3: Export Revenues of Indian Biotech Industry by
Sector (2008
-
09 & 2009
-
10): Export Value in US$ Million for
Bio
-
Pharma, Bio
-
Services, Bio
-
Agri, Bio
-
Industrial, and
Bioinformatics (includes corresponding Graph/Chart).......13


Table 4: Biotechnology Industry Export Revenues as a Percentage
Share of Total Segment Revenues: 2009
-
10 (includes
corresponding Graph/Chart).......131



Analysis by Region.......14

Western Region


Domination Continues in Revenue Terms, Mumbai
Moves to t
he


&nbspTop.......14

Table 5: Leading States in the Indian Biotech Industry by
Revenues: 2009
-
10 (includes corresponding
Graph/Chart).......141



Table 6: Leading Cities In the Indian Biotech Industry by
Revenues: 2009
-
10 (includes corresponding Graph/Ch
art).......15

Karnataka Embarks on Further Growth Plans; Other Regions Join
the League.......151


4. ISSUES AND TRENDS.......163






Government Support to the Biotechnology Sector
Surges.......16

Recognizing the Importance of Right Educational
System.....
..161



Need for a Streamlined Regulatory Process
Continues.......17

Angel Funding ?Still Eluding the Sector.......17

More Countries Look to India for Outsourcing.......171



China and India ?Competing for Biotech
Investments.......181


5. BIO
-
PHARMACEUTIC
ALS IN INDIA.......1913






Current and Future Analysis.......19

Table 7: Indian Bio
-
Pharmaceuticals Market by Segment (2010):
Percentage Share Breakdown for Vaccines, Diagnostics,
Therapeutics, and Others (includes corresponding
Graph/Chart).......191



Competitive Landscape of the Biopharma Sector.......20

Table 8: Leading BioPharma Companies in India by Revenues:
2009
-
10 (includes corresponding Graph/Chart).......201



Market Analysis by Segment.......21

Vaccines.......21

Vaccines to Spearhead Growth in

the Indian BioPharma
Market.......21

Demand for Vaccines to Surge.......211



India to Emerge as a Global Hub for Vaccines.......22

Diagnostics.......22

India Diagnostics Market ?An Overview.......22

Table 9: Leading Players in the Indian Diagnostics Mark
et by
Revenues: Market Share Breakdown of Revenues for Tulip,
TransAsia Biomedical, Bayer, Span Diagnostics, and Others (2010)
(includes corresponding Graph/Chart).......221



Indian Diagnostics Industry ?Stifled with High
Competition.......23

Diagnostic C
enters Expand Test Menu to Beat
Competition.......23

Bio
-
Therapeutics
-

Going Strong.......23

Overseas Giants Dominate the Insulin Market.......231



Plasma Proteins ?A Potential Growth Area.......24

mAbs Gain Prominence in the Biopharma Industry.......241



Market Trends.......25

Climbing Up the Value Chain.......25

Domestic Market to Provide Impetus to Bio
-
Pharma Industry
Growth.......251



Biosimilars to Offer Tremendous Prospects for Indian
Players.......26

Table 10: Indian Market for Biosimilars by Dru
g Class (2009):
Revenues for Insulin, EPO, Interferon, Streptokinase, and G
-
CSF
(includes corresponding Graph/Chart).......26

Biopharmaceutical Pipeline Growth Continues.......261



r
-
DNA Biopharmaceuticals Cleared for Pre
-
Clinical Studies:
2009
-
10.......2
71



Indian Firms Embrace Strategic Partnerships to Enter
Biotech Industry.......28

Indian Biopharma Market Luring Overseas Players.......281



Indian Pharma Companies on a Co
-
Development Spree.......29

Vaccines Remain the Center of Focus in Indian
BioPhar
ma.......291



Brighter Prospects Ahead in Original Drug
Development.......30

Myriad Factors Drive Growth in the Indian BioPharma
Sector.......301



Pharma Companies Shift Focus to BioPharma.......311


6. BIO
-
AGRICULTURE IN INDIA.......329






Current And

Future Analysis.......32

Indian Bio
-
Agriculture Industry ?An Overview.......321



Select Biotech Crops in India Under Field Trials:
2008.......331



Transgenic Crops Cleared for Limited Field Trials: 2009
-
10.......34

India ?A Leading Adopter of Biotech Cr
ops Worldwide.......34

Bio
-
Agri Treads On A Fast
-
Track Growth Path.......341



Public and Private Sector Participation in Bio
-
Agri
Research.......35

Bt Cotton ?A Major Success in India.......351



Indian Farmers Increasingly Embrace Bollgard II
Cotton.....
..36

Monsanto And Mahyco to Battle Out Pink Bollworm Resistance in
Bollgard ?I.......36

Move to Commercialize Bt Brinjal Draws Major
Controversy.......361



Government Retreats, Imposes Moratorium on Launch of Bt
Brinjal.......37

Moratorium on Bt Brinjal L
aunch, A Setback to the
Industry?.......371



Establishment of BRAI Also Faces the Heat of
Opponents.......38

Stark Criticism Compels India to Establish Transparent
Administration of Biotech


&nbspProcedures.......381



Bio
-
Diesel Market ?Still in Infancy
.......39

Bio
-
Fertilizers and Bio
-
Pesticides Market ?An
Overview.......391



Competitive Scenario in the Bio
-
Agri Sector.......40

Table 11: Leading Bio
-
Agriculture Companies in India by
Revenues: 2009
-
10 (includes corresponding
Graph/Chart).......401


7. B
IO
-
INDUSTRIAL SECTOR IN INDIA.......412






Current & Future Analysis.......41

A Peek Into The Indian Bio
-
Industrial Sector.......41

Indian Bio
-
Industrial Sector ?Fairly Concentrated.......411



Table 12: Leading Players in the Indian Bio
-
Industrial
Secto
r (2009
-
10): Market Share as Percentage of Revenues for
Novozymes, Advanced Enzyme Technologies, and Others (includes
corresponding Graph/Chart).......421


8. BIOINFORMATICS.......43






Current & Future Analysis.......43

Indian BioInformatics Market Post
s Sluggish Growth.......431


9. BIO
-
SERVICES.......442






Current And Future Analysis.......44

Indian Bio
-
Services Market Bustling with Activity.......441



India ?A Growing Hub for Clinical Trials.......45

Competitive Scenario.......45

Table 13: Leading

Biotechnology Services Companies in India By
Revenues (2009
-
10) (includes corresponding
Graph/Chart).......451


10. REGULATORY SETUP.......464






Regulatory Evolution in the Country.......46

Department of Biotechnology.......46

Public Sector Undertaking
s under the DBT.......46

Autonomous Institutions operating under the DBT.......461



Roles and Responsibilities of DBT.......47

Various Committees Operating Under the DBT and MoEF.......47

GEAC or the Genetic Engineering Approval Committee.......47

Review
Committee on Genetic Manipulation.......47

Institutional Bio
-
Safety Committee.......471



Recombinant DNA Advisory Committee.......48

Central Drugs Standard Control Organization.......48

Select Acts, guidelines and regulations that govern the
biotechnology

industry in


&nbspIndia.......481



Agencies Supporting and Financing Biotechnology Research in
India.......49

New Regulatory Framework on the Horizon.......49

National Biotechnology Strategy.......491


11. INDUSTRY INFRASTRUCTURE.......50






Biotech a
nd Science Parks in the Country.......50

Select Biotech and Science Parks in India.......50

Major Research Institutes in India.......50

Select Key Research Institutes in India.......501



Autonomous Biotechnology Institutes in India.......511


12. BIOTECHN
OLOGY ?AN OVERVIEW.......523






Biotechnology.......52

A Peek into the History of Biotechnology.......52

Select Major Applications of Biotechnology.......521



Medicine.......53

Pharmacogenomics.......53

Biopharmaceuticals.......53

Genetic Testing.......
531



Gene Therapy.......54

Cloning.......54

Agriculture.......54

Bioremediation and Biodegradation.......541


13. PRODUCT APPROVALS/LAUNCHES.......554






Panacea Biotec to Introduce PacliALL.......55

Gene Logic Rolls Out ASCENTA System Version 4.0......
.55

Bharat Biotech International Unveils HNVAC?H1N1 Swine Flu
Vaccine.......551



Strand Scientific Intelligence Introduces Avadis
NGS.......56

Dr Reddy


Rolls Out Generic Darbepoetin Alfa Drug,
Cresp?......56

BD Biosciences and ReaMetrix Unveil New Reagents.......56

Serum Institute of India Rolls Out Nasovac H1N1 Vacccine in
India.......561



Ocimum Biosolutions Introduces Biotracker?......57

Nov
o Nordisk Launches Antidiabetic Drug, Victoza in
India.......57

Cadila Healthcare Launches Vaxiflu
-
S.......571



Ocimum Biosolutions Introduces qRT
-
PCR Services.......58

Wockhardt Rolls Out Biotechnology Products.......58

Intas Biopharma Launches Borviz in

India.......58

Bharat Biotech International Unveils COMVAC5? Vaccine.......581


14. RECENT INDUSTRY ACTIVITY.......5926






Bharat Biotech Commences Phase III Clinical Trial with THR
-
100.......59

Bayer Teams Up with Zydus for Joint Venture in India......
.59

Qiagen Establishes Qiagen India.......591



Ecron Acunova Expands Capacity at Mangalore Clinical
Research Center.......60

IndianOil Inks MOU with LanzaTech.......60

Dow AgroSciences and GVK Biosciences Discover New
Compound.......60

Ecron Acunova Estab
lishes Joint Venture CRO in
Thailand.......601



Praj Industries Enters into Partnership with
Qteros.......61

Mavens Biotech to Venture into Biotech Education.......61

Aurobindo Pharma to Divest Stake in Its Chinese
Subsidiary.......611



Evolvence India L
ife Sciences Takes Over Stake in Fermenta
Biotech.......62

Strides Arcolab to Take Over 70% Stake in Inbiopro
Solutions.......62

Rallis Acquires Majority Stake in Metahelix.......62

Ocimum Secures US Million Funding for Future Growth.......621



Dr. Reddy'
s to Purchase US Penicillin Facility and Product
Rights from GSK.......63

Life Technologies to Take Over Labindia.......63

Biocon Enters into Strategic Global Agreement with
Pfizer.......631



Intas Biopharma to Ink Out
-
Licensing Deal with Japanese
Firm...
....64

Biocon Limited and CMI Enter into Immunology Research
Collaboration.......64

Biocon Signs Contract with Teleradiology Solutions.......641



Jubilant Organosys Changes Name to Jubilant Life
Sciences.......65

Jubilant Inks CRAMS Deal with a US Firm...
....65

MSCCC and Strand Life Sciences Ink MOU for Translational Cancer
Research.......651



Lohmann Animal Health Enters into Joint Venture with
Suguna.......66

International Stem Cell Inks a Distribution Agreement with
Sristi Biosciences.......66

BioServe

Biotechnologies Receives NABL Accreditation for GMO
Testing.......66

Indian Immunologicals to Develop Oral Cervical Cancer
Vaccine.......661



Piramal Healthcare to Take Over the Assets of
BioSyntech.......67

Ocimum Biosolutions to Offer BioIT Consulting
Services.......67

Zydus Obtains DCGI Clearance for Initiating Phase I Trials on
Zyog1.......671



Krishidhan Establishes Subsidiary in Europe.......68

Biocon Limited Inks Supply Deal with Optimer
Pharmaceuticals.......68

Australia to Grant Research Funding

to India.......68

Ocimum Biosolutions and Jivan Biologics Enter into
Partnership.......681



Stempeutics Completes Phase I/II Study of Stemepucel
-
CLI
Stem Cell Product.......69

Ranbaxy Enters into Alliance with Pfenex.......69

Syngene Collaborates with En
do Pharmaceuticals.......69

Panacea Biotech Obtains Financial Assistance from DBT for
Vaccine Development.......691



M. D. Anderson Cancer Center Selects Biotracker? of Ocimum
Biosolutions.......70

GVK Biosciences Establishes New Clinical Pharmacology
Uni
t.......70

Delta Embedded Solutions to merge with Bio
-
Analytical
Technologies.......701



Clingene Seeks Alliance with SIRO Clinpharm.......71

Biocon Investments in Malaysian Biotech Market.......71

Ranbaxy to Foray into Vaccines Market through Acquisition

of
Biovel's Assets.......711



Clinigene International Deploys PheedIt Solution of
SAS.......72

Bioseed Research India Inks Strategic Partnership Agreement
with KeyGene.......721



PRAJ Partners with Novozymes.......73

Mylan sells stake in Concord Biotech
.......73

Vibha Seeds Sets Up Seed Facility in Andhra Pradesh.......73

Bayer Cropscience Inks Research Cooperation Agreement with GVK
Biosciences.......731



Millipore Acquires Outstanding Stake of its Joint Venture
in India.......74

Avesthagen Forms Joint

Venture with Limagrain.......74

Indus Biotech Receives HIV Controller Status for IND02 from
FDA.......74

Bharat Biotech Commences Construction at Konark Knowledge Park
in Orissa.......741



International Biotech Park to Forge International
Alliances......
.75

Merck Acquires Bangalore Genei.......75

Bharat Biotech Secures International Patents for
Lysostaphin.......75

Genzyme Inks MoU with NIPER for Offering Biotechnology
Fellowships.......751



Biocon Enters into Agreement with Amylin
Pharmaceuticals.......
76

WHO and DCGI Direct Serum Institute of India to Focus on H1N1
Vaccine.......76

Acoris Research Enters into Strategic Partnership with c
-
LEcta.......76

Serum Institute of India to Expedite Vaccine
Development.......761



Sanofi Aventis Acquires Shantha B
iotechnics.......77

Biocon Inks a Strategic Collaboration Agreement with
Mylan.......77

Lonza to Invest in Genome Valley for Two Major
Projects.......771



Bio
-
Rad Laboratories Integrates DiaMed Scientific
Technologies in India.......78

Syngene Enters into

Alliance with DuPont Crop
Protection.......78

Emami Biotech Limited and Calcutta Tramways Company Ink
MoU.......78

TCG Lifesciences and Pfizer Extend Master Services
Agreement.......781



Biological E Commences Operations at New Campus.......79

Syngene En
ters into Partnership with Sapient.......791



Intas Biopharmaceuticals Inks MoU with Government of
Gujarat.......80

Emami


Bio
-
Diesel Obtains SGS Certification.......80

Ocimum Biosolutions Enters into Partnership with
NuGEN.......801



Biocon Collaborates

with Abraxis to Introduce Abraxane in
India.......811



Intas Biopharmaceuticals Takes Over BPD.......82

Bharat Biotech Completes Phase I/II Clinical Trials for 116E
Oral Rotavirus


&nbspVaccine.......82

Intas Biopharmaceuticals to Commercialize Gefitini
b in
India.......821



Avesthagen Inks LoI with ShigaMediX.......83

Ranbaxy Signs Collaborative Research Agreement with
DBT.......83

Veeda Establishes Global Oncology Contract Research
Organization.......83

Avesthagen Signs Framework Agreement with DuBiote
ch.......83

Biocon Buys Majority Stake in German Company.......831



Monsanto India to Sell Butachlor & Alachlor Businesses to
Sinochem


&nbspInternational.......84

Biocon Signs Strategic Partnership Agreement with
IATRICa.......84

Intas Pharmaceuticals t
o Sell Biotechnology Products in
GCC.......841


15. FOCUS ON SELECT LEADING PLAYERS.......8515






Advanced Enzymes Technologies Ltd........85

Ajeet Seeds Ltd........85

Anthem BioSciences Pvt. Ltd........851



Bharat Biotech International Limited.......86

Bharat Serums and Vaccines Ltd........861



Biocon Limited.......871



Syngene International Limited.......88

Dr. Reddy's Laboratories Ltd.......881



Ecron Acunova.......89

Eli Lilly and Company (India) Pvt. Ltd........89

GlaxoSmithKline Pharmaceuticals
Ltd........891



Indian Immunologicals Ltd........90

Jubilant Life Sciences Limited.......901



Krishidhan Seeds Private Limited.......91

Lambda Therapeutic Research Ltd........911



Mahyco.......92

Max Neeman.......92

Monsanto.......921



Novo Nordisk Ind
ia Pvt. Ltd........93

Novozymes South Asia Pvt. Ltd........931



Nuziveedu Seeds Pvt. Ltd........94

Ocimum Biosolutions Ltd........941



Panacea Biotec Ltd........95

Piramal Healthcare Limited.......951



Quintiles India.......96

Rasi Seeds (P) Ltd........
961



Reliance Life Sciences.......97

Serum Institute of India Ltd........971



Shantha Biotechnics Limited.......98

SIRO Clinpharm.......98

Strand Life Sciences.......981



Veeda Clinical Research Limited.......99

Vimta Labs Limited.......991


16. MARKET
ANALYTICS.......100






Table 14: Indian Recent Past, Current & Future Analysis for
Biotechnology Industry by Sector ?Bio
-
Pharmaceuticals, Bio
-
Agriculture, Bio
-
Industrial, Bioinformatics, and Bio
-
Services
Markets Independently Analyzed with Annual Sales i
n US$ Million
for Years 2009 through 2017 (includes corresponding
Graph/Chart).......1001



Table 15: Indian Historic Review for Biotechnology Industry
by Sector?Bio
-
Pharmaceuticals, Bio
-
Agriculture, Bio
-
Industrial,
Bioinformatics, and Bio
-
Services Markets

Independently Analyzed
with Annual Sales in US$ Million for Years 2003 through 2008
(includes corresponding Graph/Chart).......1011



Table 16: Indian 15
-
Year Perspective for Biotechnology
Industry by Sector ?Percentage Breakdown of Dollar Sales for
Bio
-
P
harmaceuticals, Bio
-
Agriculture, Bio
-
Industrial,
Bioinformatics, and Bio
-
Services Markets for Years 2003, 2010
and 2017 (includes corresponding Graph/Chart).......1021



Table 17: Indian Recent Past, Current & Future Analysis for
Bio
-
Pharmaceuticals by Segment ?Vaccines, Diagnostics,
Therapeutics, and Others Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2009 through 2017
(includes correspondin
g Graph/Chart).......1031



Table 18: Indian Historic Review for Bio
-
Pharmaceuticals by
Segment ?Vaccines, Diagnostics, Therapeutics, and Others
Markets Independently Analyzed with Annual Sales in US$ Million
for Years 2003 through 2008 (includes correspon
ding
Graph/Chart).......1041



Table 19: Indian 15
-
Year Perspective for Bio
-
Pharmaceuticals by Segment ?Percentage Breakdown of Dollar
Sales for Vaccines, Diagnostics, Therapeutics, and Others
Markets for Years 2003, 2010 and 2017 (includes corresponding
G
raph/Chart).......1051

COMPETITION289



Total Companies Profiled: 66 (including
Divisions/Subsidiaries
-

67)


Region/Country Players

Asia
-
Pacific (Excluding Japan) 67


Click here to request a full table of contents and more details
on this project.